Myogenica

Michael Kyba

8 Jul 2026, reporter.nih.gov

National Institute of Arthritis and Musculoskeletal and Skin Diseases

R42, Systemic Transplantation of MyoPAXon: IND Enabling Studies for the Treatment of DMD, R42AR083779, US$701.5k, 2023–2027, 8 Jul 2026, reporter.nih.gov

National Institute of Arthritis and Musculoskeletal and Skin Diseases

R42, Systemic Transplantation of MyoPAXon: IND Enabling Studies for the Treatment of DMD, R42AR083779, US$1.3m, 2023–2027, 24 Sept 2025, reporter.nih.gov